Piccolo Medical develops the SmartPICC® catheter navigation and tip location system aimed at improving catheter placement, especially for older adults with heart conditions. The company will use a $3 million Commercialization Readiness Pilot (CRP) grant from the National Institute on Aging (NIH) to advance and secure new regulatory approvals for the SmartPICC technology. This CRP award builds on a 2018 Phase II NIH award that supported development and clinical work for the SmartPICC, including a 42-patient, multi-center clinical study of the first-generation system. Piccolo received 510(k) clearance for the SmartPICC System in 2021. The company was spun out of the Theranova medical device incubator in San Francisco and has been funded by private investors as well as Phase I and II NIH grants. No revenue or user metrics were disclosed in the announcement. Piccolo Medical develops catheter guidance and catheter tip‑location technology for vascular access. Its core product is the SmartPICC® catheter tip location and navigation system, which received FDA 510(k) clearance in January 2021. The company intends to use new funding to further develop and commercialize its catheter guidance technology, including a next‑generation SmartPICC® system. Piccolo was spun out of the Theranova medical device incubator and is led by CEO Augustus (Augie) Shanahan. Historically it has been funded by private investors and by Phase I and II grant awards from the National Institute on Aging.

Total raised

$9M

Funding rounds

2

Latest round

Grant

Latest activity

Jan 2024